• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏搭桥手术期间血液和组织中的头孢曲松水平。

Ceftriaxone levels in blood and tissue during cardiopulmonary bypass surgery.

作者信息

Bryan C S, Morgan S L, Jordan A B, Smith C W, Sutton J P, Gangemi J D

出版信息

Antimicrob Agents Chemother. 1984 Jan;25(1):37-9. doi: 10.1128/AAC.25.1.37.

DOI:10.1128/AAC.25.1.37
PMID:6322680
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC185430/
Abstract

One gram of ceftriaxone was given intravenously to 15 patients approximately 2 h before cardiopulmonary bypass surgery. Ceftriaxone levels in plasma (mean +/- standard deviation) were 60.4 +/- 18.8 micrograms/ml (range, 17.0 to 96.0 micrograms/ml) at the beginning of bypass, 44.2 +/- 16.6 micrograms/ml (range, 9.4 to 78.6 micrograms/ml) at the end of bypass, and 19.6 +/- 9.6 micrograms/ml (range, 4.2 to 47.1 micrograms/ml) the following morning, 18.1 to 24.7 h after infusion of ceftriaxone. Concentrations in the sternal bone were 4.7 +/- 2.1 micrograms/g (range, 1.0 to 10.1 micrograms/g; tissue-to-plasma ratios, 0.066 +/- 0.036). Concentrations in the atrial appendage were 7.7 +/- 1.8 microgram/g (range, 3.6 to 10.2 micrograms/g; tissue-to-plasma ratios, 0.143 +/- 0.062). These data suggest that a single dose of ceftriaxone might be useful for prevention of infection due to susceptible pathogens.

摘要

在体外循环心脏手术前约2小时,给15名患者静脉注射1克头孢曲松。体外循环开始时血浆中头孢曲松水平(均值±标准差)为60.4±18.8微克/毫升(范围为17.0至96.0微克/毫升),体外循环结束时为44.2±16.6微克/毫升(范围为9.4至78.6微克/毫升),次日上午,即输注头孢曲松后18.1至24.7小时,为19.6±9.6微克/毫升(范围为4.2至47.1微克/毫升)。胸骨中的浓度为4.7±2.1微克/克(范围为1.0至10.1微克/克;组织与血浆比率为0.066±0.036)。心耳中的浓度为7.7±1.8微克/克(范围为3.6至10.2微克/克;组织与血浆比率为0.143±0.062)。这些数据表明,单剂量头孢曲松可能有助于预防易感病原体引起的感染。

相似文献

1
Ceftriaxone levels in blood and tissue during cardiopulmonary bypass surgery.心脏搭桥手术期间血液和组织中的头孢曲松水平。
Antimicrob Agents Chemother. 1984 Jan;25(1):37-9. doi: 10.1128/AAC.25.1.37.
2
Pharmacokinetics of ceftriaxone after intravenous infusion and intramuscular injection.静脉输注和肌内注射后头孢曲松的药代动力学
Am J Med. 1984 Oct 19;77(4C):112-6.
3
Difference in blister fluid penetration after single and multiple doses of ceftriaxone.单次和多次注射头孢曲松后水疱液渗透率的差异。
Antimicrob Agents Chemother. 1985 Jul;28(1):123-7. doi: 10.1128/AAC.28.1.123.
4
Concentrations of ceftriaxone in prostate adenoma tissue.头孢曲松在前列腺腺瘤组织中的浓度。
Chemotherapy. 1984;30(1):1-6. doi: 10.1159/000238237.
5
Crossover study of the pharmacokinetics of ceftriaxone administered intravenously or intramuscularly to healthy volunteers.头孢曲松静脉注射或肌肉注射于健康志愿者的药代动力学交叉研究。
Antimicrob Agents Chemother. 1983 Nov;24(5):812-4. doi: 10.1128/AAC.24.5.812.
6
Concentrations of ceftriaxone in serum and lung tissue.血清和肺组织中头孢曲松的浓度。
Chemotherapy. 1984;30(2):81-3. doi: 10.1159/000238250.
7
Single-dose pharmacokinetics of ceftriaxone in healthy Chinese adults.头孢曲松在中国健康成年人中的单剂量药代动力学。
Antimicrob Agents Chemother. 1985 Feb;27(2):192-6. doi: 10.1128/AAC.27.2.192.
8
Pharmacokinetics of ceftriaxone and its relation to concentrations in extravascular compartments. Comparison with cefotaxime.头孢曲松的药代动力学及其与血管外腔室浓度的关系。与头孢噻肟的比较。
Chemotherapy. 1985;31(2):85-94. doi: 10.1159/000238319.
9
Pharmacokinetic characteristics of intravenous ceftriaxone in normal adults.正常成年人静脉注射头孢曲松的药代动力学特征。
Antimicrob Agents Chemother. 1982 Nov;22(5):816-23. doi: 10.1128/AAC.22.5.816.
10
[Study on transfer of ceftriaxone into female genital organs].[头孢曲松向女性生殖器官转移的研究]
Jpn J Antibiot. 1984 Dec;37(12):2391-6.

引用本文的文献

1
Preventing deep wound infection after coronary artery bypass grafting: a review.冠状动脉搭桥术后深部伤口感染的预防:综述
Tex Heart Inst J. 2013;40(2):125-39.
2
Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.头孢曲松。对其抗菌活性、药理特性及治疗用途的综述。
Drugs. 1984 Jun;27(6):469-527. doi: 10.2165/00003495-198427060-00001.

本文引用的文献

1
Determination of cephalosporins in biological material by reversed-phase liquid column chromatography.
J Chromatogr. 1981 May 8;223(2):393-9. doi: 10.1016/s0378-4347(00)80112-7.
2
Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin.头孢曲松(Ro 13 - 9904)的抗菌活性,一种对β-内酰胺酶稳定的头孢菌素。
Antimicrob Agents Chemother. 1981 Mar;19(3):414-23. doi: 10.1128/AAC.19.3.414.
3
Mediastinitis after cardiovascular surgery.
Rev Infect Dis. 1983 Sep-Oct;5(5):885-97. doi: 10.1093/clinids/5.5.885.
4
Comparative in vitro activities of third-generation cephalosporins.第三代头孢菌素的体外活性比较
Arch Intern Med. 1983 Sep;143(9):1743-5.
5
Comparison of cefamandole and cefazolin during cardiopulmonary bypass.头孢孟多与头孢唑林在体外循环期间的比较。
J Thorac Cardiovasc Surg. 1983 Aug;86(2):222-5.
6
Bacteremia following prosthetic valve replacement.人工瓣膜置换术后的菌血症
Ann Surg. 1983 Feb;197(2):147-51. doi: 10.1097/00000658-198302000-00005.
7
Ceftriaxone: in vitro studies and clinical evaluation.头孢曲松:体外研究与临床评估。
Antimicrob Agents Chemother. 1982 Jul;22(1):1-9. doi: 10.1128/AAC.22.1.1.
8
Pharmacokinetics of ceftriaxone in humans.头孢曲松在人体内的药代动力学。
Antimicrob Agents Chemother. 1981 Nov;20(5):634-41. doi: 10.1128/AAC.20.5.634.
9
Wound infection in cardiothoracic surgery.心胸外科手术中的伤口感染
Lancet. 1983 May 28;1(8335):1209-10. doi: 10.1016/s0140-6736(83)92479-0.
10
The use of linear models and matrix least squares in clinical chemistry.
Clin Chem. 1979 Jun;25(6):840-55.